-
Miami stumble to draw against Cincinnati despite Suarez strike
-
Trump accuses Alaska Democrats of fraud over same-name scandal
-
Bangladesh scrambling as Ganges water treaty to expire
-
Spain mourns after latest train tragedy kills 68
-
England in peril with Rugby League World Cup semi spots at stake
-
Trump's border: quiet, but few people are happy
-
Antonelli ready to rewrite the Formula One record books in Mexico
-
Australian defence chief says China military buildup creating 'pressure' in SE Asia
-
EU, Canada to build 'new chapter' in alliance at Montreal summit
-
No penalty practice? No problem for Man City in shoot-out win
-
Argentine football fan jailed for threats over Di Maria return
-
Microsoft beats expectations fueled by Azure cloud business
-
Liverpool beat Chelsea in League Cup shoot-out, Man City survive scare
-
Chelsea win as Bayern draw with Madrid in Women's Champions League
-
Inter leave it late again in Serie A as AC Milan, Juventus lose
-
Kane watches as Bayern cruise into German Cup last 16
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Bayern boss Kompany out of hospital after meningeal irritation
-
Putin hails Elon Musk as 'truly a genius'
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US stocks eye big tech earnings as Fed holds rates steady
-
Chelsea win as Bayern and Madrid draw in Women's Champions League
-
US Fed holds interest rates steady despite 'too high' inflation
-
Made with munitions from the Falklands War, a 'Chalice of Peace' for the pope
-
Rwanda cannot be blamed for what happens in DR Congo, FM says
-
Pioneering US labor leader Dolores Huerta dies at 96
-
Inter leave it late again in Serie A as Bologna sink AC Milan
-
Italian PM slams 'shameful' release of alleged protest organiser
-
Bolsonaro's escape to the US: How it happened
-
Hollywood producer Kennedy to head LA28 Olympic ceremony plans
-
Russell calls on Scotland to 'kick on' and beat big teams
-
Djokovic wins Basel opener to boost ATP Finals bid
-
Airbus aims for record deliveries despite disappointing quarter
-
US Fed holds interest rates steady despite surging inflation
-
Cuba wins UN vote against US embargo with weakest backing in 30 years
-
Chiefs sign ex-Ravens kicker suspended over sex allegations
-
Real Madrid, La Liga apology over Mbappe shows power of Chinese market
-
Inglis and Carey put Australia in command of South Africa decider
-
From Gaza to Ramallah, Palestinians see little hope in Israeli vote
-
92-year-old US judge handling Maduro case dies
-
US labor leader Dolores Huerta dead: family
-
Perez extends Cadillac deal to 2029
-
Investors turn cautious ahead of tech results, Fed update on rates
-
Arab Israelis proud of high election turnout, uncertain for future
-
'Cruise for life' strands passengers in Cambodia as operator goes bust
-
Inglis, Carey put Australia in command of South Africa decider
-
Bolsonaro flees Brazil for US after election defeat
-
French firm Safran helps build aircraft wings of the future in UK factory
-
A throne on wheels, popemobiles star in new Vatican show
-
Ceasefire in Russia-occupied Ukrainian city holds for second day
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use
HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog's acquisition of Anaerobe Systems earlier this year with the objective of bringing class-leading tools for microbiology to the rapidly growing clinical, microbiome, and agricultural markets.
Today, Biolog's TruPRAS™ media is the only commercial media manufactured under true pre-reduced, anaerobically sterilized conditions, preventing the formation of harmful byproducts that can be toxic to anaerobic organisms. This line of media products, which has been approved for In Vitro Diagnostic (IVD) use by the USA FDA for years, has now also achieved CE marking under the requirements of the EU IVDR regulation 2017/746. With zero recalls or field actions throughout their extensive history, these products enable transport of specimens and growth of fastidious anaerobes that play important roles in disease pathology - supporting clinical diagnostics in medical laboratories.
"The IVDR/CE mark is a major milestone that recognizes the high standard of our anaerobic media and its value in supporting critical diagnostic workflows," said Robert Wicke, CEO at Biolog. "We're proud that clinical labs throughout Europe can now benefit from the same reliable performance that researchers and clinicians in the U.S. have trusted for decades."
Biolog's anaerobic chambers have also received the CE mark, affirming their safety and performance for use in any research settings throughout the world. With unique InstaSleeve™ technology, these ergonomic, gloveless chambers offer superior processing dexterity while working in a fully anaerobic environment and are a preferred tool for microbiologists in both clinical and academic settings. In addition, Biolog is releasing an upgrade to enable hypoxic or microaerophilic conditions in the same chamber, for organisms that require specific, low concentrations of oxygen to thrive.
"This dual achievement reinforces Biolog's commitment to advancing global access to high-quality tools for anaerobic microbiology," said Wicke. "Whether you're working with challenging clinical isolates or conducting fundamental research, Biolog now provides dependable CE-marked solutions that meet your needs."
About Biolog
Biolog offers tools, services, and support for comprehensive cellular characterization and multi-omic identification of bacteria, yeast, and fungi. Our products also enable phenotypic profiling of microbial and mammalian cells for a range of applications, including supporting the culture of fastidious anaerobes with our line of gloveless chambers and pre-reduced media. Learn more at biolog.com
Contact Information
John Proctor, Ph.D.
CCO
[email protected]
(408)306-0414
SOURCE: Biolog, Inc.
View the original press release on ACCESS Newswire
H.Weber--VB